Tyvaso and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data
Summary:
Chronic obstructive pulmonary disease is reported as a side effect among people who take Tyvaso (treprostinil sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Revatio, and have Primary pulmonary hypertension.
The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Tyvaso. It is created by eHealthMe based on reports of 37,923 people who have side effects when taking Tyvaso from the FDA, and is updated regularly.
What is Tyvaso?
Tyvaso has active ingredients of treprostinil sodium. eHealthMe is studying from 37,941 Tyvaso users. Check the latest studies of Tyvaso.
What is Chronic obstructive pulmonary disease?
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,809 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.
37,923 people reported to have side effects when taking Tyvaso.
Among them, 376 people (0.99%) have Chronic obstructive pulmonary disease.
Among these 376 people:
How long have people been on Tyvaso when they have Chronic obstructive pulmonary disease? *
What is the gender of people who have Chronic obstructive pulmonary disease when taking Tyvaso? *
What is the age of people who have Chronic obstructive pulmonary disease when taking Tyvaso? *
What are other drugs people take besides Tyvaso? *
What are other side effects people have besides Chronic obstructive pulmonary disease? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Tyvaso and have Chronic obstructive pulmonary disease?
- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Tyvaso:
- Tyvaso (37,941 reports)
Chronic obstructive pulmonary disease treatments and more:
- Chronic obstructive pulmonary disease (198,253 reports)
How severe was Chronic obstructive pulmonary disease and when was it recovered:
Expand to all the drugs that have ingredients of treprostinil sodium:
- Chronic obstructive pulmonary disease and drugs with ingredients of treprostinil sodium (554 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tyvaso:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Chronic obstructive pulmonary disease:
- Chronic obstructive pulmonary disease (1,809 drugs)
Browse all the conditions that are associated with Chronic obstructive pulmonary disease:
- Chronic obstructive pulmonary disease (2,206 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on treprostinil sodium (the active ingredients of Tyvaso) and Tyvaso (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Demerol vs. Duragesic-100, side effect and effectiveness comparison - now
- Drug interactions of Profen and Ester C - 18 seconds ago
- Could Entresto cause Monoclonal Gammopathy? - 19 seconds ago
- Could Methimazole cause Chronic Obstructive Pulmonary Disease? - 23 seconds ago
- Drug interactions of Prempro and Atenolol - 25 seconds ago
- Drug interactions of Zyrtec and Cardizem - 26 seconds ago
- Could Verapamil Hcl cause Vomiting Aggravated? - 28 seconds ago
- Could Venofer cause Fever? - 52 seconds ago
- Could Nicotine Polacrilex cause Anxiety Aggravated? - a minute ago
- Could Veletri cause Appetite Disorder? - a minute ago